Inverse dT CNA CPG Column
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
Phosphoramidite for incorporation of an (otherwise unmodified) reverse (5’ to 3’) dT nucleobase within an oligonucleotide.
Phosphoramidite used to incorporate a 5'-capped dT in an oligonucleotide.
Phosphoramidite for incorporation of an (otherwise unmodified) reverse (5’ to 3’) dT nucleobase within an oligonucleotide.
Dideoxynucleoside phosphoramidite used in nuclease blocking.
CPG useful for synthesising 2'-5' linked oligonucleotides, and effecting 3' termination.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |